- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Global Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
Nykode Therapeutics
Market Cap: NOK 532.6m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 1.63
7D
8.7%
1Y
-64.6%
Ligand Pharmaceuticals
Market Cap: US$3.3b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$169.72
7D
1.9%
1Y
74.3%
Oruka Therapeutics
Market Cap: US$563.6m
A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.
ORKA
US$15.20
7D
-2.3%
1Y
-33.4%
Promimic
Market Cap: SEK 329.7m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 17.45
7D
4.2%
1Y
-51.7%
Vericel
Market Cap: US$1.5b
A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.
VCEL
US$30.23
7D
-4.6%
1Y
-30.0%
Surrozen
Market Cap: US$102.2m
A biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair.
SRZN
US$11.56
7D
-5.9%
1Y
12.8%
Zelluna
Market Cap: NOK 255.7m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 12.50
7D
-3.8%
1Y
n/a
Bavarian Nordic
Market Cap: DKK 17.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 228.00
7D
-1.3%
1Y
-2.7%
Immunome
Market Cap: US$883.9m
A clinical-stage biotechnology company, develops targeted cancer therapies.
IMNM
US$11.59
7D
23.4%
1Y
-19.4%
Applied DNA Sciences
Market Cap: US$3.8m
A biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally.
APDN
US$4.14
7D
40.8%
1Y
-99.4%
1CM
Market Cap: CA$50.0m
Operates as a multi-jurisdictional cannabis company in Canada.
EPIC
CA$0.24
7D
-37.2%
1Y
16.7%
BioGaia
Market Cap: SEK 10.9b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 108.20
7D
-0.3%
1Y
-3.5%
Tectonic Therapeutic
Market Cap: US$275.3m
A biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs).
TECX
US$15.20
7D
1.5%
1Y
-50.3%
Oryzon Genomics
Market Cap: €241.3m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€3.06
7D
-2.7%
1Y
65.4%
Serina Therapeutics
Market Cap: US$51.0m
A biotechnology company, develops drugs to treat neurological diseases and pain.
SER
US$4.97
7D
-1.2%
1Y
-25.9%
Tango Therapeutics
Market Cap: US$886.7m
A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
TNGX
US$8.53
7D
12.2%
1Y
14.2%
Amarin
Market Cap: US$319.5m
A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
AMRN
US$16.00
7D
4.2%
1Y
32.4%
Zenas BioPharma
Market Cap: US$784.1m
A clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies.
ZBIO
US$20.09
7D
6.1%
1Y
17.2%
Almirall
Market Cap: €2.4b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
ALM
€11.22
7D
-2.1%
1Y
26.8%
VivoSim Labs
Market Cap: US$9.0m
A pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine.
VIVS
US$3.21
7D
-22.7%
1Y
-42.6%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 62.80
7D
-6.4%
1Y
-17.5%
Avalo Therapeutics
Market Cap: US$151.9m
A clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.
AVTX
US$10.80
7D
-8.7%
1Y
14.9%
Janux Therapeutics
Market Cap: US$1.3b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$23.23
7D
-0.9%
1Y
-49.8%
DiaMedica Therapeutics
Market Cap: US$353.6m
A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
DMAC
US$6.94
7D
1.8%
1Y
66.0%
Upstream Bio
Market Cap: US$879.3m
A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
UPB
US$17.26
7D
5.4%
1Y
n/a
NovaBay Pharmaceuticals
Market Cap: US$12.5m
Does not have significant operations.
NBY
US$2.19
7D
20.3%
1Y
208.5%
Immuneering
Market Cap: US$505.9m
A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.
IMRX
US$8.08
7D
-12.7%
1Y
203.8%
Lyell Immunopharma
Market Cap: US$244.4m
A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.
LYEL
US$12.83
7D
-2.0%
1Y
-57.5%
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€5.93
7D
-5.4%
1Y
-5.6%
Soligenix
Market Cap: US$6.9m
A late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States.
SNGX
US$1.20
7D
-55.4%
1Y
-68.1%
Oramed Pharmaceuticals
Market Cap: US$98.4m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$2.41
7D
3.0%
1Y
-2.8%
Cognition Therapeutics
Market Cap: US$111.2m
A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
CGTX
US$1.33
7D
-5.0%
1Y
216.1%
Artiva Biotherapeutics
Market Cap: US$73.5m
A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.
ARTV
US$2.96
7D
2.8%
1Y
-78.9%
Connect Biopharma Holdings
Market Cap: US$94.2m
A clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States.
CNTB
US$1.58
7D
0.6%
1Y
17.0%
Anixa Biosciences
Market Cap: US$111.1m
A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.
ANIX
US$3.40
7D
3.0%
1Y
6.6%
Roivant Sciences
Market Cap: US$10.2b
A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.
ROIV
US$15.17
7D
0.9%
1Y
32.1%